- Corporate Officers - G
- Greer R Scott
Insider Trading History of Greer R Scott
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Greer R Scott since 2005.
This trader's CIK number is 1211703.
At the time of last reporting, Greer R Scott was the Director of Nektar Therapeutics. (stock ticker symbol NKTR).
Also see all insider trading activities at Nektar Therapeutics.
Note that in the past
GREER R SCOTT also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Auspex Pharmaceuticals, Inc. (ASPX) by Greer R Scott
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ASPX | 5,190 | $99,907 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Inogen Inc (INGN) by Greer R Scott
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | INGN | 0 | $0 | 0 | $0 | 20,000 | $893,740 |
Yearly summary of insider trading at Sirna Therapeutics Inc (RNAI) by Greer R Scott
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | RNAI | 37,500 | $60,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aravive, Inc. (VSAR) by Greer R Scott
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | VSAR | 15,500 | $196,475 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Greer R Scott
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | NKTR | 0 | $0 | 0 | $0 | 97,500 | $1,283,500 |
| 2020 | NKTR | 0 | $0 | 15,009 | $375,225 | 40,000 | $369,600 |
| 2019 | NKTR | 0 | $0 | 0 | $0 | 10,000 | $51,400 |
| 2018 | NKTR | 0 | $0 | 50,000 | $4,043,286 | 50,000 | $530,600 |
| 2016 | NKTR | 15,000 | $202,500 | 0 | $0 | 15,000 | $0 |
| 2015 | NKTR | 0 | $0 | 0 | $0 | 32,500 | $368,550 |
| 2013 | NKTR | 0 | $0 | 0 | $0 | 7,500 | $0 |
| 2011 | NKTR | 0 | $0 | 0 | $0 | 3,333 | $0 |
Insider trading activities at 5 companies by Greer R Scott:
1. Auspex Pharmaceuticals, Inc. (ASPX)
2. Inogen Inc (INGN)
3. Sirna Therapeutics Inc (RNAI)
4. Aravive, Inc. (VSAR)
5. Nektar Therapeutics (NKTR)
Table 1. Insider trading of Auspex Pharmaceuticals, Inc. (ASPX) by Greer R Scott
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-07-16 | ASPX | Buy | 5,190 | 19.25 | 99,907 |
Table 2. Insider trading of Inogen Inc (INGN) by Greer R Scott
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-03 | INGN | Option Ex | 20,000 | 44.69 | 893,740 |
Table 3. Insider trading of Sirna Therapeutics Inc (RNAI) by Greer R Scott
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-07-06 | RNAI | Buy | 37,500 | 1.60 | 60,000 |
Table 4. Insider trading of Aravive, Inc. (VSAR) by Greer R Scott
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-11-11 | VSAR | Buy | 10,000 | 10.16 | 101,600 |
| 2015-01-27 | VSAR | Buy | 5,500 | 17.25 | 94,875 |
Table 5. Insider trading of Nektar Therapeutics (NKTR) by Greer R Scott
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-09 | NKTR | Option Ex | 12,500 | 12.80 | 160,000 |
| 2021-08-31 | NKTR | Option Ex | 45,000 | 12.70 | 571,500 |
| 2021-01-05 | NKTR | Option Ex | 40,000 | 13.80 | 552,000 |
| 2020-07-09 | NKTR | Option Ex | 40,000 | 9.24 | 369,600 |
| 2020-07-09 | NKTR | Sale | 15,009 | 25.00 | 375,225 |
| 2019-03-08 | NKTR | Option Ex | 10,000 | 5.14 | 51,400 |
| 2018-09-04 | NKTR | Option Ex | 10,000 | 5.14 | 51,400 |
| 2018-09-04 | NKTR | Sale | 10,000 | 67.39 | 673,900 |
| 2018-06-04 | NKTR | Option Ex | 1,400 | 5.14 | 7,196 |
| 2018-06-04 | NKTR | Sale | 1,400 | 61.99 | 86,786 |
| 2018-06-06 | NKTR | Option Ex | 8,600 | 5.14 | 44,204 |
| 2018-06-06 | NKTR | Sale | 8,600 | 60.00 | 516,000 |
| 2018-04-06 | NKTR | Sale | 30,000 | 92.22 | 2,766,600 |
| 2018-04-06 | NKTR | Option Ex | 30,000 | 14.26 | 427,800 |
| 2016-10-24 | NKTR | Buy | 15,000 | 13.50 | 202,500 |
| 2016-09-15 | NKTR | Option Ex | 15,000 | .00 | 0 |
| 2015-10-15 | NKTR | Option Ex | 32,500 | 11.34 | 368,550 |
| 2013-02-01 | NKTR | Option Ex | 7,500 | .00 | 0 |
| 2011-03-08 | NKTR | Option Ex | 3,333 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Greer R Scott
(Director of Nektar Therapeutics at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.